Prognostic Factors and Survival in Patients Treated Surgically for Recurrent Metastatic Uterine Leiomyosarcoma

Table 2

Characteristics	Number	%
57 years (37–82)
FIGO stage
I	14	58%
II	4	17%
III	3	13%
IV	3	13%
Grade
Low	4	17%
High	20	83%
Treatment at initial diagnosis
Surgery alone	12	50%
Surgery + (CT and/or RT)	12	50%
Time to first recurrence after initial diagnosis
<12 months	13	54%
≥12 months	11	46%
Single isolated recurrence
Cervix	3	13%
Lung	4	17%
Intestines	4	17%
	11	46%
Multiple site recurrence
Abdomen*/lung/bone	2	8%
Pelvis/lung	2	8%
Pelvis/intestines	3	13%
Retroperitoneum	6	25%
	13	54%
	24	100%
1 tumor versus ≥2 tumors
1 tumor	12	50%
≥2 tumors	12	50%
Treatment at first recurrence
Surgery alone	10	42%
Surgery + (CT and/or rads)	14	58%
Resection
Complete resection	16	67%
Residual microscopic	3	13%
Residual macroscopic	5	21%

∗One with bone metastasis.